Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed Altai

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
EJNMMI Research|March 25, 2026
Fractionation gives therapeutic benefit in animal model of [<sup>177</sup>Lu]Lu-PSMA-617 therapy of prostate cancerOskar Vilhelmsson Timmermand, Axel Östholm, Wahed Zedan, et al.
Chemistryopen|May 14, 2015
Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of RadioactivityJoanna Strand, Patrik Nordeman, Hadis Honarvar, et al.
Scientific Reports|May 11, 2024
Hematological and renal toxicity in mice after three cycles of high activity [<sup>177</sup>Lu]Lu-PSMA-617 with or without human α<sub>1</sub>-microglobulinAmanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, et al.
Biomaterials|March 17, 2019
Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargetingKristina Westerlund, Anzhelika Vorobyeva, Bogdan Mitran, et al.
Theranostics|January 2, 2016
Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant TumorsHadis Honarvar, Kristina Westerlund, Mohamed Altai, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 28, 2024
Intratumoral Distribution of [<sup>177</sup>Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate CancerAnders Örbom, Joanna Strand, Mohamed Altai, et al.
Amino Acids|May 17, 2011
Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody moleculesMohamed Altai, Helena Wållberg, Anna Orlova, et al.
Bioconjugate Chemistry|March 30, 2011
Evaluation of a maleimido derivative of NOTA for site-specific labeling of affibody moleculesVladimir Tolmachev, Mohamed Altai, Mattias Sandström, et al.
Nuclear Medicine and Biology|December 17, 2011
Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGAMohamed Altai, Anna Perols, Amelie Eriksson Karlström, et al.
Cancers|August 17, 2019
Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug ConjugatesHaozhong Ding, Mohamed Altai, Sara S Rinne, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
EJNMMI Research|March 25, 2026
Fractionation gives therapeutic benefit in animal model of [<sup>177</sup>Lu]Lu-PSMA-617 therapy of prostate cancerOskar Vilhelmsson Timmermand, Axel Östholm, Wahed Zedan, et al.
Chemistryopen|May 14, 2015
Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of RadioactivityJoanna Strand, Patrik Nordeman, Hadis Honarvar, et al.
Scientific Reports|May 11, 2024
Hematological and renal toxicity in mice after three cycles of high activity [<sup>177</sup>Lu]Lu-PSMA-617 with or without human α<sub>1</sub>-microglobulinAmanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, et al.
Biomaterials|March 17, 2019
Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargetingKristina Westerlund, Anzhelika Vorobyeva, Bogdan Mitran, et al.
Theranostics|January 2, 2016
Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant TumorsHadis Honarvar, Kristina Westerlund, Mohamed Altai, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 28, 2024
Intratumoral Distribution of [<sup>177</sup>Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate CancerAnders Örbom, Joanna Strand, Mohamed Altai, et al.
Amino Acids|May 17, 2011
Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody moleculesMohamed Altai, Helena Wållberg, Anna Orlova, et al.
Bioconjugate Chemistry|March 30, 2011
Evaluation of a maleimido derivative of NOTA for site-specific labeling of affibody moleculesVladimir Tolmachev, Mohamed Altai, Mattias Sandström, et al.
Nuclear Medicine and Biology|December 17, 2011
Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGAMohamed Altai, Anna Perols, Amelie Eriksson Karlström, et al.
Cancers|August 17, 2019
Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug ConjugatesHaozhong Ding, Mohamed Altai, Sara S Rinne, et al.
Pageof 7